Clinical Trial Update: Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the addition of dexmedetomidine to benzodiazepines for ICU patients with alcohol withdrawal has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Bogomolets National Medical University | Conditions: Alcohol Withdrawal State | Phase 4 | Status: COMPLETED